Virology News
62.3K views | +2 today
Follow
 
Scooped by Ed Rybicki
onto Virology News
Scoop.it!

Russell Kightley's Scientific Illustration Blog: Influenza Virus Structure Animation

Russell Kightley's Scientific Illustration Blog: Influenza Virus Structure Animation | Virology News | Scoop.it

"I have just created an animation of a rotating influenza virus. The sequence begins with a still of the cutaway virus with various parts labelled. The labels disappear and the virus rotates, then returns to the starting graphic. This is in high definition and looks good full screen on a 27" iMac. It is the latest addition to my YouTube Channel."

 

Definitely, graphics courtesy of Russell Kightley Media...B-)  STRONGLY commended!

No comment yet.
Virology News
Topical news snippets about viruses that affect people.  And other things. Like Led Zeppelin. And zombies B-)
Curated by Ed Rybicki
Your new post is loading...
Your new post is loading...
Scooped by Ed Rybicki
Scoop.it!

PDB-101: Goodsell Gallery: Coronavirus Life Cycle

PDB-101: Goodsell Gallery: Coronavirus Life Cycle | Virology News | Scoop.it

This illustration shows a cross section through a cell infected with a coronavirus such as SARS-CoV-2. It shows a time point when the virus is actively replicating, and new viruses are being created. The cell’s molecules are shown in blues and greens, and the viral molecules are shown in pinks and purples. The illustration integrates the current state of knowledge, but many aspects of the virus and its life cycle are still actively being studied, so portions of the painting are speculative. Additional resources for exploring coronavirus are available at PDB-101 and the main RCSB PDB site.


Ed Rybicki's insight:
Share your insight
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

COVAXIN: India’s First Indigenous COVID-19 Vaccine Candidate To Begin Human Trials Next Week

COVAXIN: India’s First Indigenous COVID-19 Vaccine Candidate To Begin Human Trials Next Week | Virology News | Scoop.it
The human trials will be conducted in two phases on more than 1,100 people in total.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Is COVID-19 even subject to herd immunity?

Is COVID-19 even subject to herd immunity? | Virology News | Scoop.it
Without a vaccine, scientists say it's highly unlikely we'll ever reach herd immunity for the novel coronavirus.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Remdesivir can save more COVID patients where hospitals are maxed out

Remdesivir can save more COVID patients where hospitals are maxed out | Virology News | Scoop.it
With news that the US bought almost the entire global supply of remdesivir, new research shows the drug saves more lives in places with overwhelmed ICUs.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

South Africa rolls out continent's first trials for COVID-19 vaccine

South Africa rolls out continent's first trials for COVID-19 vaccine | Virology News | Scoop.it
Oxford University rolled out Africa's first human trials for a potential vaccine against the new coronavirus in South Africa on Wednesday, as cases continue to rise and concerns grow over potential access to life-saving treatments.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Cross-Sectional Study on the Sero- and Viral Dynamics of Porcine Circovirus Type 2 in the Field

Cross-Sectional Study on the Sero- and Viral Dynamics of Porcine Circovirus Type 2 in the Field | Virology News | Scoop.it
Porcine circovirus-associated diseases (PCVADs) cause considerable economic losses in industrial pork production in the field. To minimize the economic losses due to PCVAD, porcine circovirus type 2 (PCV2) vaccines have been developed, and there is widespread vaccination worldwide today.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

'We are not guinea pigs,' say South African anti-vaccine protesters

'We are not guinea pigs,' say South African anti-vaccine protesters | Virology News | Scoop.it
Anti-vaccine protesters took to the streets in Johannesburg on Wednesday to voice their concern over Africa's first human trials for a potential coronavirus vaccine.
Ed Rybicki's insight:
Dumb as fuck.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Experimental COVID-19 Vaccine Shows Positive Early Results in Human Trial

Experimental COVID-19 Vaccine Shows Positive Early Results in Human Trial | Virology News | Scoop.it
BioNTech of Germany and the US pharmaceutical giant Pfizer reported positive preliminary results on Wednesday from a joint project to develop a coronavirus vaccine.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

The objective of this Personal View is to compare transmissibility, hospitalisation, and mortality rates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with those of other epidemic coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Chinese COVID-19 vaccine approved to enter Phase III clinical trial in Brazil 

Beijing-based Sinovac Life Sciences Co announced on Monday that its COVID-19 vaccine collaboration with Brazilian immunobiologic producer Instituto Butantan has received approval from the Brazilian regulator for phase III clinical trials.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Quasar upends ideas about black hole formation

Quasar upends ideas about black hole formation | Virology News | Scoop.it
A new discovery "presents the biggest challenge yet for the theory of black hole formation and growth in the early universe."...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

A brave new way to bring the coronavirus vaccine to the masses

A brave new way to bring the coronavirus vaccine to the masses | Virology News | Scoop.it
SINGAPORE - The world has faced no other crisis in recent times that has so highlighted our need for global cooperation.. Read more at straitstimes.com.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

COVID-19 affects human neurons, mini-brains show

COVID-19 affects human neurons, mini-brains show | Virology News | Scoop.it
Does COVID-19 affect the brain? A new study shows that the coronavirus can infect the human brain cells and multiply.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

China's Sinovac starts late-stage trials for COVID-19 vaccine | News | Al Jazeera

China's Sinovac starts late-stage trials for COVID-19 vaccine | News | Al Jazeera | Virology News | Scoop.it
Study will recruit nearly 9,000 healthcare professionals working in COVID-19 specialised facilities in Brazil.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization | Virology News | Scoop.it
The real-time RT-PCR multiplex test is intended for the simultaneous detection and differentiation of SARS-CoV-2, influenza A virus, and influenza B virus.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Ensuring Uptake of Vaccines against SARS-CoV-2 | NEJM

Ensuring Uptake of Vaccines against SARS-CoV-2 | NEJM | Virology News | Scoop.it
Ensuring Uptake of Vaccines against SARS-CoV-2 Although a SARS-CoV-2 vaccine remains months to years away, now is the time to develop a policy strategy to ensure vaccine uptake — including consider...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Minister Blade Nzimande on funding awards to South Africa Coronavirus Covid-19 testing ability 

Department of Science and Innovation ramp up funding awards to South Africa Covid-19 Testing Ability The Department of Science and Innovation (DSI), the South African Medical Research Council (SAMRC) and the Technology Innovation Agency (TIA), a DSI entity made seven funding awards to local companies, organisations and researchers in order to ramp up the country's ability to produce locally developed reagents and test kits for COVID-19. The awards are valued at about R18 million with the funding recipients set to commence with their responsibility immediately with approximately six months to begin production.
Ed Rybicki's insight:
And we got some B-)
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Fluorescent protein tagging of adenoviral proteins pV and pIX reveals ‘late virion accumulation compartment’

Fluorescent protein tagging of adenoviral proteins pV and pIX reveals ‘late virion accumulation compartment’ | Virology News | Scoop.it
Author summary Understanding the regulation of adenovirus morphogenesis is not only of interest to cell biologists but is also key to define novel drug targets as well as to optimize adenoviruses as tools for gene therapy.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Bunny Ebola: The Mysterious Virus Killing House Rabbits

Bunny Ebola: The Mysterious Virus Killing House Rabbits | Virology News | Scoop.it
A mysterious, highly infectious virus known as rabbit hemorrhagic disease virus type 2 is causing house rabbits throughout the U.S. to suddenly drop dead.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Stroke appears 8 times more likely with COVID than with flu

Stroke appears 8 times more likely with COVID than with flu | Virology News | Scoop.it
Both flu and COVID-19 can raise your risk for a stroke, but the odds appear to be eight times higher with the coronavirus, a new study finds.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

China says G4 swine flu virus not new; does not infect humans easily

China says G4 swine flu virus not new; does not infect humans easily | Virology News | Scoop.it
SHANGHAI/BEIJING — China’s Ministry of Agriculture and Rural Affairs said on Saturday that the so-called “G4” strain of swine flu virus is not new and does not infect or sic…...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

SARS-CoV-2 seroprevalence in COVID-19 hotspots

SARS-CoV-2 seroprevalence in COVID-19 hotspots | Virology News | Scoop.it
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surprised the world with its range of disease manifestations, from asymptomatic infection to critical illness leading to hospital admission and death.1,2 Due to the high proportion of asymptomatic or mild infections (approximately...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study

medRxiv - The Preprint Server for Health Sciences...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

The line is forming for a COVID-19 vaccine. Who should be at the front?

The line is forming for a COVID-19 vaccine. Who should be at the front? | Virology News | Scoop.it
U.S.and World Health Organization are already debating how to prioritize the initial distribution of a coveted vaccine...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Inovio’s coronavirus vaccine candidate delivers promising results in Phase 1 trial 

Inovio’s coronavirus vaccine candidate delivers promising results in Phase 1 trial  | Virology News | Scoop.it
Inovio released a coronavirus vaccine update to announce that its experimental DNA drug generated immune responses in 94% of volunteers enrolled in Phase 1 trials. The company is part of the US government’s Operation Warp Speed initiative to fast-track the development of COVID-19 vaccines.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Aussie human trials for local vaccine start

Aussie human trials for local vaccine start | Virology News | Scoop.it
One of Australia's COVID-19 vaccine candidates made by South Australian company Vaxine is kicking off its human trials in Adelaide on Thursday.
Ed Rybicki's insight:
Good on yer, mates!
No comment yet.